Clarity
Do they understand what you do?
14 could name what kind of product this is, unprompted.
https://cambrianalliance.co.uk/15 AI-simulated buyers
Your message needs work: they know what it is, who it's for, and why it's worth their time, but not why to pick you.
Do they understand what you do?
14 could name what kind of product this is, unprompted.
Can they tell what it solves, and who it's for?
15 could quickly tell what problem it solves and who it is for.
Do they actually want it?
15 would take a meeting to learn more.
Is there a reason to pick you over the alternatives?
8 could name a reason to pick you over a similar option.
Your page describes: pharmacy ordering automation. They said:
12 couldn't name one; 3 got it right.
Four separate measures, not stages: all 15 personas answered all four questions. Each square is one persona.
Two respondents said the pitch targets single-site owners and never mentions multi-site purchasing, despite that being their key use case. Not one of the four layers, and it does not affect the scores above or the order to fix them in.
These are 15 simulated buyers. Want 15 real ones?
Test with humansThe first is on your weakest layer, the second on the next, the third on the layer the most buyers had a problem with. Each says what to change on the page and why, with one simulated answer behind it.
Why: "Order via your PMR, e-CASS Web or both" and "across every supplier" name nothing. Buyers judging stack fit need the actual PMR systems and wholesaler names listed on the page.
Why: With no cost anywhere, readers cannot weigh the gain against their existing PMR purchasing. Publish the model — per-site fee, percentage of savings — even if the number is on request.
2 of 15 raised this
“"total control over how you buy", "a whole lot more", and "cascade system" never get unpacked into an actual sequence of what happens when an order pad is built and a rule fires; I had to infer the mechanism from the feature bullets rather than being shown it.”
Why: The 5-7% figure arrives with no baseline, sample or period, so it reads as a brochure number. Name the pharmacy type, the measurement window and what it was compared against.
6 of 15 raised this
“A verified margin uplift I can attribute directly to the tool - not a self-reported 5-7% from one dispensary, but something I can check against my own purchasing data after a live trial period”
These landed. Keep the wording when you edit around it.
The opening lines make the audience and the problem obvious
“The reader is clearly a pharmacy - the customer quotes are named pharmacists/pharmacies (Nat Mitchell at JWW Allison's Chemist, Mo Nazemi at Evans Pharmacy, Edward Down at a Medical Practice)”
Automating manual wholesaler price comparison is the value respondents could repeat back
“I'd stop paying someone to manually cross-check wholesaler price lists every week”
Why: "Our cascade system enables multiple ways to control your ordering" names a mechanism and leaves readers to reverse-engineer it from bullets. State what the cascade does: ranks wholesalers by your rules and routes each line to the cheapest compliant supplier.
Why: Nothing on the page says whether this is a neutral price comparator or a wholesaler selling its own stock — the difference decides whether the recommendations can be trusted. Add a line stating the company's position and independence from suppliers.
No specific edits needed here — this layer held up.
Why: "Customise your pharmacy's settings" is singular throughout, so group and multi-site buyers read the page as built for one shop. Say how settings, cascades and reporting work across a group.
1 of 15 raised this
“The tone is written for a pharmacy owner-operator who's also doing the dispensing themselves — "you don't have the time to oversee the endless complexities" and the kitchen price-list story — which is close to me but a notch below my level; I'm running purchasing across multiple sites and thinking about margin at a portfolio level, and the page never really speaks to that multi-site reality”
A deliberately adversarial read of the same answers. Each claim was checked back against what the personas said and dropped if nothing supported it.
The page's entire commercial case rests on one number nobody believes.
Six of 15 respondents rejected the 5-7% claim for lacking source, baseline, scale and timeframe, with several demanding a live trial first. No other proof point appears anywhere in the themes.
Buyers can restate the benefit but cannot act on it, so the page generates recall without pipeline.
Three respondents repeated the price-comparison benefit unprompted, yet six distrusted the savings figure, five could not judge stack fit and three could not compare on price. Comprehension is not the bottleneck; evidence is.
The page cannot survive a procurement conversation because every commercial input is missing.
Three respondents said absent pricing blocks comparison against existing PMR purchasing, and five wanted named PMR and wholesaler integrations plus switching disruption detail. There is nothing to build a business case from.
The product reads as generic, which hands the win to any competitor that names systems.
Five respondents said that without named PMR systems and wholesaler integrations the product reads as a generic pharmacy tool, and one flagged the missing list of named wholesalers as critical.
The page hides who is selling, which kills trust before the savings claim is even tested.
Two respondents could not tell whether the company is a neutral wholesaler or owns suppliers, and the missing 'About us' left them guessing at firm size. Neutrality is the core question in a purchasing tool.
Naming the cascade without explaining it signals insider fluency the page never earns.
Two respondents said abstract mechanisms are left unpacked and must be inferred from feature bullets. A mechanism the reader has to reverse-engineer from bullets is not a differentiator.
The cascade mechanism is named but never explained
2 of 15
“"total control over how you buy", "a whole lot more", and "cascade system" never get unpacked into an actual sequence of what happens when an order pad is built and a rule fires; I had to infer the mechanism from the feature bullets rather than being shown it.”
“there's no pricing, no mention of switching effort or PMR compatibility, and no detail on how many wholesalers are actually in the cascade”
The company's own position in the supply chain is unstated
2 of 15
“What's missing that would confirm the size/maturity guess is any "About us," headcount, or how long they've operated - right now it's an inference from tone and specificity, not a stated fact”
The opening lines make the audience and the problem obvious
4 of 15 · what worked
“The reader is clearly a pharmacy - the customer quotes are named pharmacists/pharmacies (Nat Mitchell at JWW Allison's Chemist, Mo Nazemi at Evans Pharmacy, Edward Down at a Medical Practice)”
“The customer quotes (Nat Mitchell, a chemist; Mo Nazemi, a pharmacy; a dispensary manager talking about generics margins) confirm it's aimed at independent pharmacy owners or dispensary managers like me”
“Actually it wasn't hard to pin down what it does - I understood the concept fine on first read. If anything the slight friction was words like "cascade" and "e-CASS Web" used before being defined”
“the top of the page says "You don't have the time to oversee the endless complexities of ordering stock, you need a system that does the work for you" and then "e-CASS gives you total control over how you buy" - so within the first two lines I knew it's a stock-ordering automation tool”
PMR integration and switching costs are absent, so buyers cannot judge stack fit
4 of 15
“I'd need to see our actual daily wholesalers named in the cascade list, plus a line saying it plugs into the specific PMR we run — right now it's generic enough to apply to any pharmacy, and I want proof it's built for my exact stack, not just "pharmacies" in the abstract.”
“it just doesn't tell me anything about how e-CASS integrates with my existing PMR setup or switching costs, which is what I'd actually need to know.”
“what would push it further is if it named my specific PMR system by brand, since that's the detail that would tell me they've actually built for my setup and not just pharmacies in general”
“no detail on PMR compatibility (which PMR systems does it integrate with - mine specifically?), no mention of switching time or setup disruption, and no pricing shown”
“If a competitor's page named their wholesaler panel explicitly and this one doesn't, that gap alone would tip me toward the other option, because "every supplier" with no list attached is exactly the kind of vague claim that burned me before.”
That same 5-7% figure is not trusted without methodology, timeframe or sample
6 of 15
“A verified margin uplift I can attribute directly to the tool - not a self-reported 5-7% from one dispensary, but something I can check against my own purchasing data after a live trial period”
“it's one quote from one dispensary, no scale or timeframe attached, so I'd want to know what happened for a pharmacy my size before I'd believe it applies to me”
“A verified, sourced 5-7% profitability uplift with the baseline and sample size disclosed — if that number holds up on a call, it's worth my time; if it's just a quote with no data behind it, it isn't.”
“Edward Down's quote about profitability rising 5-7% from blocking over-tariff orders is the kind of concrete outcome that would actually matter to my margins. But that number has no source or timeframe”
“The 5-7% profitability claim from the Caythorpe testimonial is the closest thing to proof, but it's a single anecdote with no baseline shown - I'd want to see that across a sample of pharmacies before I believed it applies broadly.”
Automating manual wholesaler price comparison is the value respondents could repeat back
3 of 15 · what worked
“I'd stop paying someone to manually cross-check wholesaler price lists every week”
“a purchasing/procurement automation tool for pharmacies, aimed at cutting admin time and boosting margins”
“It's an automated purchasing/ordering system for pharmacies - something that sits alongside your PMR and manages a "cascade" of wholesaler prices so you're always buying at the cheapest available price, blocking over-tariff orders and tracking margins.”
Missing pricing blocks any competitive comparison
2 of 15
“the real question is whether e-CASS adds meaningfully on top of what I do now rather than just formalising it - the page doesn't tell me the cost or the switching effort”
“there's no pricing, no mention of switching effort or PMR compatibility, and no detail on how many wholesalers are actually in the cascade”
“no detail on PMR compatibility (which PMR systems does it integrate with - mine specifically?), no mention of switching time or setup disruption, and no pricing shown”
Multi-site operators do not see themselves in the page
1 of 15
“The tone is written for a pharmacy owner-operator who's also doing the dispensing themselves — "you don't have the time to oversee the endless complexities" and the kitchen price-list story — which is close to me but a notch below my level; I'm running purchasing across multiple sites and thinking about margin at a portfolio level, and the page never really speaks to that multi-site reality”
“I'd need a line naming multi-site or group purchasing explicitly, something like "manage purchasing rules across all your branches from one dashboard" plus a testimonial from someone running more than one site, not just single-dispensary owners like JWW Allison's or Evans Pharmacy.”
15 AI-simulated personas matched to your target market. Each answered independently, without seeing your goal, the scoring criteria, or each other’s answers. Attribution is role, industry and company size only.
Every answer on this page was written by an AI model role-playing a buyer profile, scored on Wynter’s B2B Message Layers framework. The personas were sampled in code across role, industry, company size and behavioral traits; the model wrote only the answers. Scores arrive through fixed verdict categories and the counts are computed in our own code, so no number here was written by a model.
The count is how many personas cleared the bar on each question. A yes can be unhesitating or come with reservations; the scorecard counts both as a yes, and this is the only place the difference is shown. Per layer:
These answers are AI-simulated and directional. Validate anything you’re betting on with real buyers, your ICPs.
A detailed, section-by-section message test report from verified B2B professionals who are actually in-market for what you sell.







